Nanosphere Inc. (NSPH) 1.69 $NSPH
Nanosphere Announces Intent to Voluntarily Delist From NASDAQ Capital Market
GlobeNewswire - Mon Jun 20, 3:01PM CDT
Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it notified the NASDAQ Capital Market ("NASDAQ"
of its intent to file a Form 25 with the Securities and Exchange Commission on or about June 30, 2016, following the expiration of the Tender Offer (as defined below), to initiate the voluntary delisting of the Company's common stock (the "Common Stock" from NASDAQ in anticipation of the closing of the merger of Commodore Acquisition, Inc. ("Merger Sub", a wholly owned subsidiary of Luminex Corporation, with and into Nanosphere, on or about June 30, 2016. The official delisting of the Securities will be effective ten days after Nanosphere files the Form 25.
LMNX: 19.95 (+0.26), NSPH: 1.69 (-0.01)
Luminex Corporation Announces Commencement of Tender Offer for All Outstanding Shares of Nanosphere, Inc. Common Stock
PR Newswire - Thu Jun 02, 5:00AM CDT
Luminex Corporation (NASDAQ: LMNX) announced today that its wholly-owned subsidiary Commodore Acquisition, Inc. has commenced its previously announced tender offer to purchase all outstanding shares of common stock of Nanosphere, Inc. (NASDAQ: NSPH) for $1.70 per share in cash. The tender offer is being made pursuant to the Agreement and Plan of Merger entered into and among Luminex, Commodore, and Nanosphere dated May 15, 2016 as subsequently amended.
LMNX: 19.95 (+0.26), NSPH: 1.69 (-0.01)
Luminex Corporation and Nanosphere, Inc. Provide Update on Acquisition Agreement
PR Newswire - Mon May 23, 5:00AM CDT
Luminex Corporation (NASDAQ: LMNX) and Nanosphere, Inc. (NASDAQ: NSPH) announced today that they have entered into an amendment to the definitive agreement under which Luminex will acquire Nanosphere, a leader in the molecular microbiology and molecular diagnostic market. The purchase price has been increased to $1.70 per share from $1.35 per share in an all cash transaction valued at approximately $77 million. This increase was in response to an unsolicited third party offer for Nanosphere at $1.50 per share.
LMNX: 19.95 (+0.26), NSPH: 1.69 (-0.01)
SHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Nanosphere, Inc.
BusinessWire - Fri May 20, 5:35PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Nanosphere, Inc. ("Nanosphere" or "the Company" (Nasdaq: NSPH) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Luminex Corporation ("Luminex".
LMNX: 19.95 (+0.26), NSPH: 1.69 (-0.01)
NANOSPHERE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Nanosphere, Inc. (NSPH) Over the Proposed Sale of the Company to Luminex Corporation
BusinessWire - Fri May 20, 3:22PM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Nanosphere, Inc. ("Nanosphere" or the "Company" (NASDAQ:NSPH) for potential breaches of fiduciary duties in connection with the sale of the Company to Luminex Corporation for approximately $58 million in an all-cash transaction.
LMNX: 19.95 (+0.26), NSPH: 1.69 (-0.01)
NANOSPHERE, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
BusinessWire - Thu May 19, 2:40PM CDT
Rigrodsky & Long, P.A.:
NSPH: 1.69 (-0.01)
Nanosphere, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Luminex Corporation
BusinessWire - Thu May 19, 1:34PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Nanosphere, Inc. ("Nanosphere" (NASDAQ: NSPH) concerning the merger with Luminex Corporation. Under the terms of the agreement, valued at approximately $58 million, Nanosphere shareholders will only receive $1.35 per share held. The consideration is significantly lower than at least one analyst's estimated value of $1.65.
LMNX: 19.95 (+0.26), NSPH: 1.69 (-0.01)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Nanosphere, Inc. -NSPH
PR Newswire - Wed May 18, 7:49PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Nanosphere, Inc. ("Nanosphere" or "the Company" (Nasdaq: NSPH) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Luminex Corporation ("Luminex".
LMNX: 19.95 (+0.26), NSPH: 1.69 (-0.01)
SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Nanosphere, Inc. and Encourages Investors to Contact the Firm for Additional Information
BusinessWire - Tue May 17, 3:41PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Nanosphere, Inc. ("Nanosphere" or the "Company" (Nasdaq: NSPH) relating to the proposed buyout of the Company by Luminex Corporation.
NSPH: 1.69 (-0.01)
Luminex (LMNX) to Buy Nanosphere, Eyes Portfolio Expansion
Zacks Equity Research - Zacks Investment Research - Tue May 17, 7:02AM CDT
Luminex Corp (LMNX) is set to acquire IL-based biotech company Nanosphere (NSPH) for almost $58 million ($1.35 per share) in cash.
IRMD: 21.68 (+0.34), EW: 98.92 (+0.88), LMNX: 19.95 (+0.26), NSPH: 1.69 (-0.01)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale of Nanosphere, Inc. to Luminex Corporation for $1.35 Per Share - NSPH
ACCESSWIRE - Mon May 16, 10:03AM CDT
NEW YORK, NY / ACCESSWIRE / May 16, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
LMNX: 19.95 (+0.26), NSPH: 1.69 (-0.01)
Nanosphere Announces First Quarter Results
GlobeNewswire - Mon May 16, 5:00AM CDT
Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today reported financial results for the first quarter March 31, 2016.
NSPH: 1.69 (-0.01)
Luminex Corporation Signs Definitive Agreement to Acquire Nanosphere, Inc.
PR Newswire - Mon May 16, 5:00AM CDT
Luminex Corporation (NASDAQ: LMNX) and Nanosphere, Inc. (NASDAQ: NSPH) today announced that the companies have entered into a definitive agreement under which Luminex will acquire Nanosphere, a leader in the molecular microbiology and molecular diagnostic market for $1.35 per share in an all cash transaction valued at approximately $58 million. With its focus on the molecular microbiology segment, Nanosphere delivers proprietary diagnostic tools that enable rapid and accurate detection of respiratory, gastroenteric and bloodstream infections. The Boards of Directors of both companies have unanimously approved the merger, which is expected to immediately accelerate total revenue growth.
LMNX: 19.95 (+0.26), NSPH: 1.69 (-0.01)
Nanosphere's Verigene BC-GP Decreases Patient Length of Stay
GlobeNewswire - Thu Mar 03, 7:00AM CST
Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced publication of a study that demonstrates the clinical and economic impact of implementing rapid sepsis diagnostic testing with the Company's FDA-cleared Verigene(R) Gram-Positive Blood Culture Test (BC-GP) in a pediatric patient population.
NSPH: 1.69 (-0.01)
Nanosphere Announces Record Preliminary Q4 and Full Year 2015 Results
GlobeNewswire - Wed Jan 06, 3:01PM CST
-- Preliminary Fourth Quarter Revenue of $6.8 Million
NSPH: 1.69 (-0.01)
Verigene(R) BC-GN Positioned to Provide Rapid Diagnosis of "Phantom Menace" Superbug
GlobeNewswire - Wed Dec 23, 7:00AM CST
Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, confirms that the Verigene(R) Gram-Negative Blood Culture Test (BC-GN) is the only FDA-cleared test with the ability to rapidly identify the antibiotic resistance gene associated with a dangerous new superbug.
NSPH: 1.69 (-0.01)
Nanosphere, Inc. Announces Completion of $10 Million Registered Public Offering
GlobeNewswire - Tue Dec 22, 3:04PM CST
Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, today announced the completion of its previously announced public offering of the company's common stock for total gross proceeds of approximately $10 million.
NSPH: 1.69 (-0.01)
Nanosphere, Inc. Announces $10 Million Registered Public Offering
GlobeNewswire - Thu Dec 17, 5:32PM CST
Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, today announced the pricing of a public offering of the company's common stock with expected total gross proceeds of approximately $10 million. The offering is expected to close on or about December 22, 2015, subject to satisfaction of customary closing conditions.
NSPH: 1.69 (-0.01)
Nanosphere Announces Record Q3 2015 Results
GlobeNewswire - Mon Nov 09, 3:01PM CST
Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today reported financial and operating results for the third quarter ended September 30, 2015.
NSPH: 1.69 (-0.01)
Nanosphere Announces Intent to Voluntarily Delist From NASDAQ Capital Market
GlobeNewswire - Mon Jun 20, 3:01PM CDT
Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it notified the NASDAQ Capital Market ("NASDAQ"
of its intent to file a Form 25 with the Securities and Exchange Commission on or about June 30, 2016, following the expiration of the Tender Offer (as defined below), to initiate the voluntary delisting of the Company's common stock (the "Common Stock" from NASDAQ in anticipation of the closing of the merger of Commodore Acquisition, Inc. ("Merger Sub", a wholly owned subsidiary of Luminex Corporation, with and into Nanosphere, on or about June 30, 2016. The official delisting of the Securities will be effective ten days after Nanosphere files the Form 25. LMNX: 19.95 (+0.26), NSPH: 1.69 (-0.01)
Luminex Corporation Announces Commencement of Tender Offer for All Outstanding Shares of Nanosphere, Inc. Common Stock
PR Newswire - Thu Jun 02, 5:00AM CDT
Luminex Corporation (NASDAQ: LMNX) announced today that its wholly-owned subsidiary Commodore Acquisition, Inc. has commenced its previously announced tender offer to purchase all outstanding shares of common stock of Nanosphere, Inc. (NASDAQ: NSPH) for $1.70 per share in cash. The tender offer is being made pursuant to the Agreement and Plan of Merger entered into and among Luminex, Commodore, and Nanosphere dated May 15, 2016 as subsequently amended.
LMNX: 19.95 (+0.26), NSPH: 1.69 (-0.01)
Luminex Corporation and Nanosphere, Inc. Provide Update on Acquisition Agreement
PR Newswire - Mon May 23, 5:00AM CDT
Luminex Corporation (NASDAQ: LMNX) and Nanosphere, Inc. (NASDAQ: NSPH) announced today that they have entered into an amendment to the definitive agreement under which Luminex will acquire Nanosphere, a leader in the molecular microbiology and molecular diagnostic market. The purchase price has been increased to $1.70 per share from $1.35 per share in an all cash transaction valued at approximately $77 million. This increase was in response to an unsolicited third party offer for Nanosphere at $1.50 per share.
LMNX: 19.95 (+0.26), NSPH: 1.69 (-0.01)
SHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Nanosphere, Inc.
BusinessWire - Fri May 20, 5:35PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Nanosphere, Inc. ("Nanosphere" or "the Company"
(Nasdaq: NSPH) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Luminex Corporation ("Luminex". LMNX: 19.95 (+0.26), NSPH: 1.69 (-0.01)
NANOSPHERE SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Nanosphere, Inc. (NSPH) Over the Proposed Sale of the Company to Luminex Corporation
BusinessWire - Fri May 20, 3:22PM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Nanosphere, Inc. ("Nanosphere" or the "Company"
(NASDAQ:NSPH) for potential breaches of fiduciary duties in connection with the sale of the Company to Luminex Corporation for approximately $58 million in an all-cash transaction. LMNX: 19.95 (+0.26), NSPH: 1.69 (-0.01)
NANOSPHERE, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
BusinessWire - Thu May 19, 2:40PM CDT
Rigrodsky & Long, P.A.:
NSPH: 1.69 (-0.01)
Nanosphere, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Luminex Corporation
BusinessWire - Thu May 19, 1:34PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Nanosphere, Inc. ("Nanosphere"
(NASDAQ: NSPH) concerning the merger with Luminex Corporation. Under the terms of the agreement, valued at approximately $58 million, Nanosphere shareholders will only receive $1.35 per share held. The consideration is significantly lower than at least one analyst's estimated value of $1.65. LMNX: 19.95 (+0.26), NSPH: 1.69 (-0.01)
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Nanosphere, Inc. -NSPH
PR Newswire - Wed May 18, 7:49PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Nanosphere, Inc. ("Nanosphere" or "the Company"
(Nasdaq: NSPH) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Luminex Corporation ("Luminex". LMNX: 19.95 (+0.26), NSPH: 1.69 (-0.01)
SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Nanosphere, Inc. and Encourages Investors to Contact the Firm for Additional Information
BusinessWire - Tue May 17, 3:41PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Nanosphere, Inc. ("Nanosphere" or the "Company"
(Nasdaq: NSPH) relating to the proposed buyout of the Company by Luminex Corporation. NSPH: 1.69 (-0.01)
Luminex (LMNX) to Buy Nanosphere, Eyes Portfolio Expansion
Zacks Equity Research - Zacks Investment Research - Tue May 17, 7:02AM CDT
Luminex Corp (LMNX) is set to acquire IL-based biotech company Nanosphere (NSPH) for almost $58 million ($1.35 per share) in cash.
IRMD: 21.68 (+0.34), EW: 98.92 (+0.88), LMNX: 19.95 (+0.26), NSPH: 1.69 (-0.01)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale of Nanosphere, Inc. to Luminex Corporation for $1.35 Per Share - NSPH
ACCESSWIRE - Mon May 16, 10:03AM CDT
NEW YORK, NY / ACCESSWIRE / May 16, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:
LMNX: 19.95 (+0.26), NSPH: 1.69 (-0.01)
Nanosphere Announces First Quarter Results
GlobeNewswire - Mon May 16, 5:00AM CDT
Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today reported financial results for the first quarter March 31, 2016.
NSPH: 1.69 (-0.01)
Luminex Corporation Signs Definitive Agreement to Acquire Nanosphere, Inc.
PR Newswire - Mon May 16, 5:00AM CDT
Luminex Corporation (NASDAQ: LMNX) and Nanosphere, Inc. (NASDAQ: NSPH) today announced that the companies have entered into a definitive agreement under which Luminex will acquire Nanosphere, a leader in the molecular microbiology and molecular diagnostic market for $1.35 per share in an all cash transaction valued at approximately $58 million. With its focus on the molecular microbiology segment, Nanosphere delivers proprietary diagnostic tools that enable rapid and accurate detection of respiratory, gastroenteric and bloodstream infections. The Boards of Directors of both companies have unanimously approved the merger, which is expected to immediately accelerate total revenue growth.
LMNX: 19.95 (+0.26), NSPH: 1.69 (-0.01)
Nanosphere's Verigene BC-GP Decreases Patient Length of Stay
GlobeNewswire - Thu Mar 03, 7:00AM CST
Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced publication of a study that demonstrates the clinical and economic impact of implementing rapid sepsis diagnostic testing with the Company's FDA-cleared Verigene(R) Gram-Positive Blood Culture Test (BC-GP) in a pediatric patient population.
NSPH: 1.69 (-0.01)
Nanosphere Announces Record Preliminary Q4 and Full Year 2015 Results
GlobeNewswire - Wed Jan 06, 3:01PM CST
-- Preliminary Fourth Quarter Revenue of $6.8 Million
NSPH: 1.69 (-0.01)
Verigene(R) BC-GN Positioned to Provide Rapid Diagnosis of "Phantom Menace" Superbug
GlobeNewswire - Wed Dec 23, 7:00AM CST
Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, confirms that the Verigene(R) Gram-Negative Blood Culture Test (BC-GN) is the only FDA-cleared test with the ability to rapidly identify the antibiotic resistance gene associated with a dangerous new superbug.
NSPH: 1.69 (-0.01)
Nanosphere, Inc. Announces Completion of $10 Million Registered Public Offering
GlobeNewswire - Tue Dec 22, 3:04PM CST
Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, today announced the completion of its previously announced public offering of the company's common stock for total gross proceeds of approximately $10 million.
NSPH: 1.69 (-0.01)
Nanosphere, Inc. Announces $10 Million Registered Public Offering
GlobeNewswire - Thu Dec 17, 5:32PM CST
Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, today announced the pricing of a public offering of the company's common stock with expected total gross proceeds of approximately $10 million. The offering is expected to close on or about December 22, 2015, subject to satisfaction of customary closing conditions.
NSPH: 1.69 (-0.01)
Nanosphere Announces Record Q3 2015 Results
GlobeNewswire - Mon Nov 09, 3:01PM CST
Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today reported financial and operating results for the third quarter ended September 30, 2015.
NSPH: 1.69 (-0.01)
